Alzheimer's Disease Trial, Recruiting (NCT03020381)

Alzheimer's Disease Trial, Recruiting NCT03020381 Sponsor: Manuel Montero Odasso Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03020381 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 60 and 85 years old
People who have not been diagnosed with dementia
People who are able to walk 10 metres on their own without using any walking aid, such as a walker or cane

Who may not be able to join:

People who are unable to understand English
People who have Parkinson's disease or any other nervous system condition that affects movement, such as stroke or epilepsy
People who have a muscle or joint condition, detected during a physical examination, that affects the way they walk
People who have active osteoarthritis affecting the legs or hips at the time of clinical assessment
People who are currently taking certain medications that can affect movement, such as antipsychotics or benzodiazepines (sedatives)
People who have severe depression, as measured by a score above 12 out of 15 on a standard depression screening tool called the Geriatric Depression Scale

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. Manuel Montero Odasso, M.D., Director, Gait and Brain Lab

Phone: 5196854292

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03020381

Sponsor: Manuel Montero Odasso

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 5196854292

More information: https://clinicaltrials.gov/study/NCT03020381

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 60 and 85 years old
People who have not been diagnosed with dementia
People who are able to walk 10 metres on their own without using any walking aid, such as a walker or cane

Who may not be able to join:

People who are unable to understand English
People who have Parkinson's disease or any other nervous system condition that affects movement, such as stroke or epilepsy
People who have a muscle or joint condition, detected during a physical examination, that affects the way they walk
People who have active osteoarthritis affecting the legs or hips at the time of clinical assessment
People who are currently taking certain medications that can affect movement, such as antipsychotics or benzodiazepines (sedatives)
People who have severe depression, as measured by a score above 12 out of 15 on a standard depression screening tool called the Geriatric Depression Scale

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Manuel Montero Odasso

Registry

ClinicalTrials.gov

Start date

1 December 2007

Est. completion

1 January 2033

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Progression to Dementia; Type of Dementia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov